Ampersand Capital Partners, a middle-market private equity firm, has closed its latest fund, Ampersand 2026 (AMP-26), at its $1.5 billion hard cap after less than five months of fundraising.
Nordic private equity firm Axcel has acquired four medical device distributors — Apodan, PartnerMed, AllweCare, and XboXLab — operating across the Nordics and Benelux, to merge and establish Sanviva, a European medical device distribution network.
A new major UK-wide framework for Healthcare AI Solutions, with a maximum spend ceiling of £750–900 million (~€867–1,040 mn) to be spent over eight years (2027–2035), has been launched. What does it mean for providers and investors?
Private equity fundraising appears to be gaining momentum, with several healthcare-focused firms announcing sizeable closes in recent weeks. The blog explores where capital is being directed.
Grundium, a Finland-based digital pathology imaging company backed by US private equity firm EW Healthcare Partners, has acquired Denmark-based AI precision pathology software provider Visiopharm. The deal aims to create an integrated digital pathology platform combining imaging and AI-driven diagnostics.
Ennov, a France-based life sciences software company, has secured a growth investment led by US private equity firm Bregal Sagemount, with participation from private investment firm Ardian.
Luxembourg-based private equity firm CVC Capital, through CVC Fund IX, and Belgian investment firm Groupe Bruxelles Lambert (GBL) have launched a €10.7 billion ($12.4 billion) cash offer for all outstanding ordinary shares to take Italian pharmaceutical firm Recordati private.
The UK Competition and Markets Authority (CMA) has provisionally accepted US healthcare REIT Welltower’s offer to divest certain care homes out of the 600+ it bought last year. The CMA had raised concerns about the impact on local competition dynamics in certain areas where a large portion of the care homes would now be owned by Welltower.
The global healthcare M&A landscape in 2026 sits at an unusual juncture. The wider economy is facing a lot of headwinds and feels increasingly uncertain, whilst the usual private equity strategies aren’t working as smoothly as before. Healthcare is still seen as one of the strongest sectors to invest in around the world, however, and may even benefit from the shift away from software and tech-enabled services.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
